NDA Group

Upplands Vasby, Sweden Founded: 1997 • Age: 29 yrs Acquired By SSI Strategy
Regulatory, pharmacovigilance and quality assurance services

About NDA Group

NDA Group is a Healthcare company based in Upplands Vasby (Sweden) founded in 1997, and was acquired by SSI Strategy in August 2023. It operates as a regulatory, pharmacovigilance and quality assurance services. NDA Group offers products and services including Regulatory Strategy Services, Agency Engagement Services, and Global Dossier Preparation. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its competitors include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack and 3 more; 3 of its 8 listed competitors have raised funding.

Company details

NDA Group offers drug development consultancy services for life science for the development and commercialization of medical therapies. They have over 150 dedicated consultants with industry and regulatory backgrounds and also a support network of over 1000 scientific, clinical, regulatory and drug development experts. The company claims to have supported 40 of the new medicinal products that were approved in the EU during 2013-2016. They offer their services right from preclinical stage to the post marketing stage and encompass all regulated areas such as regulatory assessment, pharmacovigilance, quality assurance and health technology assessment (HTA). The company merged with PharmApprove, a scientific communications firm based out of the US in 2016. Their clientele includes top 10 pharma companies, mid-size and small pharma companies, among others.

  • Headquarters Upplands Vasby, Sweden
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ndareg.com
  • Social LinkedIn X Facebook
  • Acquired by SSI Strategy (Aug 2023)
Key Metrics

Products & Services of NDA Group

NDA Group offers a comprehensive portfolio of products and services, including Regulatory Strategy Services, Agency Engagement Services, and Global Dossier Preparation.

Regulatory Strategy Services
Consulting

Offers planning for drug approval processes and risk management.

Agency Engagement Services
Regulatory Support

Facilitates interactions with FDA and EMA for compliance.

Global Dossier Preparation
Documentation

Creates multi-jurisdictional dossiers for international approvals.

Investors in NDA Group

NDA Group has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SSI Strategy.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Pharmacovigilance and medical affairs services are offered for drug development.
2010ssistrategy.comParsippany Troy Hills, United States
Premium access

Investor details for NDA Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of NDA Group

2 dated milestones of NDA Group across 26 years, from founding to its latest funding, stage changes and deals.

  1. Founded NDA Group is founded.
  2. Exit Acquired by SSI Strategy.

Competitors of NDA Group

NDA Group has 8 listed competitors in our database, 3 of them funded. They include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indegene.com1998Princeton, United States$220M350
Suite solutions are provided for payers and healthcare providers.
integrichain.com2005Philadelphia, United States$2M320
Inventory, order and customer relationship management solution for life science suppliers.
clinigengroup.com2010Burton-on-trent, United Kingdom––
Specialty medicines are supplied via clinical trials and access programs.
zuelligpharma.com1992Singapore––
Healthcare access in Asia is enhanced by Zuellig Pharma.
fishawack.com2001Brighton, United Kingdom$23.59M45
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
sciencegroup.com1995Cambridge, United Kingdom–431
Technology-based consultancy and product development services are provided.
diaceutics.com2005Belfast, United Kingdom–133
Precision medicine integration is facilitated through analytics and services.
clearviewhcp.com2008Newton, United States–381
Strategic consulting services are provided to life sciences companies.
Premium access

Detailed competitors of NDA Group

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of NDA Group

Websites that share an audience with NDA Group (ndareg.com).

Similar websites

Websites whose visitors overlap most with NDA Group. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
quality-vectors.com
quality-vectors.com
100%
–––
lionpharm.com
lionpharm.com
100%
–––
tracservices.co.uk
tracservices.co.uk
100%
–––
sci-nc.com
sci-nc.com
100%
–––
kemic.com
kemic.com
100%
–––
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 16 similar websites and full traffic analytics for NDA Group

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as NDA Group (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Nda Group

Premium access

Complete news archive for NDA Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NDA Group

NDA Group was founded in 1997.

NDA Group is headquartered in Upplands Vasby, Sweden. It is registered at Upplands Vasby, Stockholm County, Sweden.

NDA Group offers drug development consultancy services for life science for the development and commercialization of medical therapies. They have over 150 dedicated consultants with industry and regulatory backgrounds and also a support network of over 1000 scientific, clinical, regulatory and drug development experts. The company claims to have supported 40 of the new medicinal products that were approved in the EU during 2013-2016. They offer their services right from preclinical stage to the post marketing stage and encompass all regulated areas such as regulatory assessment, pharmacovigilance, quality assurance and health technology assessment (HTA). The company merged with PharmApprove, a scientific communications firm based out of the US in 2016. Their clientele includes top 10 pharma companies, mid-size and small pharma companies, among others.

NDA Group's top competitors include Indegene, Zuellig Pharma and IntegriChain.

NDA Group offers Regulatory Strategy Services, Agency Engagement Services, and Global Dossier Preparation.

NDA Group has 1 investor. Key investors include SSI Strategy.

Yes. NDA Group was acquired by SSI Strategy in August 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available